The use of CM from WT or Pdia3−/− MEF specifically indicated a requirement for PDIA3 for fibroblast-secreted products that are supportive of MDA-MB-231 breast cancer cell spreading and migration. The gene discussed is PDIA3; the disease is breast carcinoma.